Brawn Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

3.00

3.00

3.00

3.00

3.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

0.36

2.06

3.31

4.22

5.79

Loan funds

Secured loans

-

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

3.36

5.07

6.31

7.22

8.80

Uses of funds

Fixed assets

Gross block

1.02

0.78

0.77

0.67

0.38

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.56

0.45

0.40

0.29

0.24

Net block

0.46

0.33

0.37

0.39

0.14

Capital work-in-progress

-

-

-

-

-

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

20.03

14.26

14.16

13.40

13.73

Less : current liabilities & provisions

17.13

9.52

8.22

6.56

5.08

Total net current assets

2.90

4.73

5.94

6.83

8.65

Miscellaneous expenses not written

-

-

-

-

-

Total

3.36

5.07

6.31

7.22

8.80

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

30.00

30.00

30.00

30.00

30.00